News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,043 Results
Type
Article (60481)
Company Profile (436)
Press Release (731104)
Multimedia
Podcasts (146)
Webinars (24)
Section
Business (222529)
Career Advice (2965)
Deals (38368)
Drug Delivery (130)
Drug Development (87980)
Employer Resources (197)
FDA (17660)
Job Trends (16557)
News (377969)
Policy (36905)
Tag
Academia (2964)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (54855)
ALS (143)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (220)
Approvals (17677)
Artificial intelligence (444)
Autoimmune disease (66)
Automation (25)
Bankruptcy (393)
Best Places to Work (12420)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (265)
Bladder cancer (121)
Brain cancer (51)
Breast cancer (470)
Cancer (3740)
Cardiovascular disease (329)
Career advice (2505)
Career pathing (37)
CAR-T (238)
CDC (55)
Cell therapy (645)
Cervical cancer (32)
Clinical research (72809)
Collaboration (1353)
Company closure (4)
Compensation (920)
Complete response letters (58)
COVID-19 (2921)
CRISPR (81)
C-suite (566)
Cystic fibrosis (127)
Data (4196)
Decentralized trials (2)
Denatured (47)
Depression (106)
Diabetes (437)
Diagnostics (7004)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (199)
Drug pricing (185)
Drug shortages (35)
Duchenne muscular dystrophy (199)
Earnings (93276)
Editorial (54)
Employer branding (25)
Employer resources (169)
Events (126821)
Executive appointments (978)
FDA (20031)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1213)
Gene editing (172)
Generative AI (35)
Gene therapy (526)
GLP-1 (1003)
Government (5192)
Grass and pollen (7)
Guidances (335)
Healthcare (20531)
HIV (46)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (234)
Immuno-oncology (19)
Indications (51)
Infectious disease (3149)
Inflammatory bowel disease (182)
Inflation Reduction Act (15)
Influenza (90)
Intellectual property (184)
Interviews (570)
IPO (17458)
IRA (59)
Job creations (4535)
Job search strategy (2064)
Kidney cancer (15)
Labor market (72)
Layoffs (619)
Leadership (32)
Legal (9173)
Liver cancer (91)
Longevity (12)
Lung cancer (535)
Lymphoma (257)
Machine learning (27)
Management (65)
Manufacturing (606)
MASH (136)
Medical device (14551)
Medtech (14571)
Mergers & acquisitions (21776)
Metabolic disorders (1124)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (220)
Neuropsychiatric disorders (57)
Neuroscience (2667)
NextGen: Class of 2025 (7316)
Non-profit (4975)
Now hiring (57)
Obesity (549)
Opinion (301)
Ovarian cancer (123)
Pain (161)
Pancreatic cancer (164)
Parkinson's disease (237)
Partnered (25)
Patents (410)
Patient recruitment (297)
Peanut (57)
People (64293)
Pharmaceutical (112)
Pharmacy benefit managers (26)
Phase I (22567)
Phase II (31865)
Phase III (23860)
Pipeline (2637)
Policy (289)
Postmarket research (3050)
Preclinical (9859)
Press Release (72)
Prostate cancer (191)
Psychedelics (51)
Radiopharmaceuticals (279)
Rare diseases (641)
Real estate (6876)
Recruiting (77)
Regulatory (26038)
Reports (62)
Research institute (2648)
Resumes & cover letters (465)
Rett syndrome (15)
RNA editing (13)
RSV (69)
Schizophrenia (132)
Series A (203)
Series B (150)
Service/supplier (19)
Sickle cell disease (79)
Special edition (24)
Spinal muscular atrophy (164)
Sponsored (38)
Startups (4081)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (93)
The Weekly (97)
Vaccines (1010)
Venture capital (66)
Weight loss (385)
Women's health (56)
Worklife (21)
Date
Last 7 days (588)
Last 30 days (2213)
Last 365 days (32409)
2025 (24870)
2024 (37385)
2023 (42301)
2022 (53530)
2021 (58279)
2020 (57108)
2019 (50504)
2018 (38345)
2017 (35485)
2016 (35734)
2015 (41774)
2014 (35919)
2013 (31368)
2012 (33416)
2011 (34027)
2010 (32691)
Location
Africa (1012)
Alabama (75)
Alaska (7)
Arizona (289)
Arkansas (14)
Asia (46572)
Australia (8098)
California (9178)
Canada (2807)
China (867)
Colorado (390)
Connecticut (400)
Delaware (253)
Europe (102553)
Florida (1365)
Georgia (309)
Hawaii (3)
Idaho (64)
Illinois (765)
India (47)
Indiana (444)
Iowa (18)
Japan (310)
Kansas (120)
Kentucky (36)
Louisiana (19)
Maine (67)
Maryland (1228)
Massachusetts (6850)
Michigan (301)
Minnesota (551)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (25)
Nevada (106)
New Hampshire (75)
New Jersey (2532)
New Mexico (31)
New York (2520)
North Carolina (1348)
North Dakota (10)
Northern California (4162)
Ohio (279)
Oklahoma (21)
Oregon (43)
Pennsylvania (1927)
Puerto Rico (19)
Rhode Island (45)
South America (1393)
South Carolina (46)
South Dakota (1)
Southern California (3531)
Tennessee (148)
Texas (1428)
United States (33822)
Utah (273)
Virginia (237)
Washington D.C. (83)
Washington State (782)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
792,043 Results for "sonoma pharma formerly known as oculus innovative sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sonoma Biotherapeutics Appoints Lisa Taylor Ash, JD, as Chief Legal Officer
August 26, 2025
·
2 min read
Press Releases
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
October 8, 2025
·
3 min read
Press Releases
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 25, 2025
·
3 min read
Press Releases
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
August 8, 2025
·
11 min read
Press Releases
Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine...
October 6, 2025
·
3 min read
Press Releases
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
August 13, 2025
·
3 min read
Press Releases
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
September 23, 2025
·
8 min read
Policy
NHS Mulls Greater Pharma Spending to Head Off Trump’s Tariffs: Report
The British proposal to increase support for pharma is “clearly positive,” according to analysts at Leerink, who noted that the NHS’ move will improve patient access to treatments.
October 10, 2025
·
2 min read
·
Tristan Manalac
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
Talks between pharma and successive U.K. governments have failed to deliver the market access terms that the industry wants, contributing to a pullback in investment.
October 1, 2025
·
4 min read
·
Nick Paul Taylor
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
1 of 79,205
Next
